Mounjaro (tirzepatide) injection
Mounjaro (tirzepatide) injection is an injection that’s given under the skin. It’s a medication that’s used together with diet and exercise to improve blood sugar control in adults with Type 2 diabetes. Mounjaro tirzepatide was approved by the FDA in May 2022 as the first one in a new class of medications.
Dosage forms
- 4 pens of 2.5mg/0.5ml,
- 4 pens of 5mg/0.5ml
- 4 pens of 7.5mg/0.5ml
- 4 pens of 10mg/0.5ml
- 4 pens of 12.5mg/0.5ml
- 4 pens of 15mg/0.5ml
Typical dosing for Mounjaro (tirzepatide)
The typical starting dose is 2.5 mg injected under the skin of the stomach, thigh, or upper arm once weekly. After 4 weeks, your provider will raise your dose to 5 mg injected once weekly. Depending on your response, your provider might continue to raise your dose every 4 weeks or so until you’re at a dose that works for you. The maximum recommended dose is 15 mg once weekly.
How Mounjaro (tirzepatide) works
Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by acting like GLP-1 and GIP, two hormones released by your gut after you eat to help you control blood sugar. These hormones tell your body to release more insulin, release less sugar, and slow down digestion. All of these actions help lower blood sugar levels. In people who have Type 2 diabetes, GLP-1 and GIP don’t work as well they should. So Mounjaro (tirzepatide) helps by acting just like GLP-1 and GIP to help control blood sugar.
Serious Side Effects
- Serious allergic reaction: hives; trouble breathing; swelling of your lips, tongue, throat, or face
- Dangerously low blood sugar: feeling hungry, fast heartbeat, shakiness, anxiety, sweating, tingling, dizziness, weakness, drowsiness, confusion
- Kidney damage: nausea, vomiting, trouble urinating, muscle cramps, feeling confused, swelling in the ankles or feet, trouble breathing
Reviews
There are no reviews yet.